Salidroside protects mice from high-fat diet-induced obesity by modulating the gut microbiota
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110278 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Jiuxi Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun 130062, People's Republic of China; Guangzhou…. Hauptthemen laut MEDLINE: Diet, High-Fat, Gastrointestinal Microbiome. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Obesity is a systemic disease with multisystem inflammation associated with gut dysbiosis. Salidroside (SAL) which is a major glycoside extracted from Rhodiola rosea L. has a wide range of pharmacological effects, but the role of gut microbiota in the protective effects of SAL on obesity has not been studied. Herein, we aim to explore whether SAL could ameliorate high-fat diet (HFD)-induced obesity in mice by modulating microbiota. Results showed that oral treatment with SAL alleviated HFD-induced obesity in mice as evidenced by body weight and fat weight. SAL supplementation effectively attenuated fat accumulation, lipid synthesis genes expression, liver inflammation, and metabolic endotoxemia. In addition, SAL treatment alleviated intestinal damage and increased the expression of mucin protein (Mucin-2) and tight junction (TJ) proteins (Occludin and Zonula Occludens-1). 16S rRNA sequencing analysis revealed that the gut microbiota of obese mice was also partly improved by SAL via restoring the microbial community structure and diversity. A fecal microbiota transplantation (FMT) study was designed to verify the causality. Compared with fecal transplantation (FM) from the HFD-treated mice, FM from the SAL-treated mice significantly mitigate the symptoms of obese mice, including decreasing body weight, fat accumulation, and attenuating pathological damage in the gut. Thus, SAL could be a remarkable candidate to prevent obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun 130062, People's Republic of China; Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Gua…
- Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun 130062, People's Republic of China.
- Department of Colorectal and Anal Surgery, The First Hospital of Jilin University, Changchun 130021, People's Republic of China. Electronic address: taijd@jlu.edu.cn.
- Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun 130062, People's Republic of China; Key Laboratory for Zoonosis Research, Ministry of Education, College of Veterin…
Förderung
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Liu, J., Cai, J., Fan, P., Dong, X., Zhang, N., Tai, J., & Cao, Y. (2023). Salidroside protects mice from high-fat diet-induced obesity by modulating the gut microbiota. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110278
Vancouver
Liu J, Cai J, Fan P, Dong X, Zhang N, Tai J, et al. Salidroside protects mice from high-fat diet-induced obesity by modulating the gut microbiota. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110278
BibTeX
@article{Liu2023,
author = {Liu, Jiuxi and Cai, Jiapei and Fan, Peng and Dong, Xue and Zhang, Naisheng and Tai, Jiandong and Cao, Yongguo},
title = {Salidroside protects mice from high-fat diet-induced obesity by modulating the gut microbiota},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110278}
}
EUVIMED